BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10383884)

  • 21. Tamoxifen. 'A big deal,' but a complex hand to play.
    Marshall E
    Science; 1998 Apr; 280(5361):196. PubMed ID: 9565527
    [No Abstract]   [Full Text] [Related]  

  • 22. Should tamoxifen users be screened for endometrial lesions?
    Neven P; Vergote I
    Lancet; 1998 Jan; 351(9097):155-7. PubMed ID: 9449866
    [No Abstract]   [Full Text] [Related]  

  • 23. [Is there a basis for prevention of breast cancer with drugs?].
    Klemetsdal B
    Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1493-5. PubMed ID: 9198929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gynaecological aspects of tamoxifen treatment in breast cancer patients.
    Obwegeser R; Auerbach L; Kubista E
    Cancer Treat Rev; 1997; 23(5-6):289-304. PubMed ID: 9465881
    [No Abstract]   [Full Text] [Related]  

  • 25. Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry.
    Martin EA; Brown K; Gaskell M; Al-Azzawi F; Garner RC; Boocock DJ; Mattock E; Pring DW; Dingley K; Turteltaub KW; Smith LL; White IN
    Cancer Res; 2003 Dec; 63(23):8461-5. PubMed ID: 14679010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary multiple neoplasm of the endometrium and adjuvant hormone therapy in patients with breast cancer].
    Bakhidze EV; Maksimov SIa; Barash NIu; Berstein LM; Semiglazov VF; Sheĭko EV; Novik VI
    Vopr Onkol; 1998; 44(2):170-4. PubMed ID: 9615821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen in cancer therapy: minireview.
    Novotny L; Rauko P; Vachálková A; Peterson-Biggs M
    Neoplasma; 2000; 47(1):3-7. PubMed ID: 10870680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
    Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
    Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer chemoprevention.
    Mamounas EP
    Hematol Oncol Clin North Am; 2000 Jun; 14(3):727-38. PubMed ID: 11203331
    [No Abstract]   [Full Text] [Related]  

  • 30. Toxicity of antiestrogens.
    Hirsimäki P; Aaltonen A; Mäntylä E
    Breast J; 2002; 8(2):92-6. PubMed ID: 11896754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of the main outcomes in breast-cancer prevention trials.
    Cuzick J; Powles T; Veronesi U; Forbes J; Edwards R; Ashley S; Boyle P
    Lancet; 2003 Jan; 361(9354):296-300. PubMed ID: 12559863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention of breast cancer by tamoxifen: risks and opportunities.
    Smith LL; White IN
    Toxicol Lett; 1995 Dec; 82-83():181-6. PubMed ID: 8597049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Commentary on endometrial cancer deaths in tamoxifen-treated breast cancer patients.
    Fisher B
    J Clin Oncol; 1996 Mar; 14(3):1027-39. PubMed ID: 8622007
    [No Abstract]   [Full Text] [Related]  

  • 34. Hormonal strategies for the prevention of breast cancer.
    Olsen MR; Love RR
    Cancer Treat Res; 1998; 94():135-57. PubMed ID: 9587686
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs.
    Yang G; Nowsheen S; Aziz K; Georgakilas AG
    Pharmacol Ther; 2013 Sep; 139(3):392-404. PubMed ID: 23711794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aromatase inhibitors: a safety comparison.
    Jonat W; Hilpert F; Kaufmann M
    Expert Opin Drug Saf; 2007 Mar; 6(2):165-74. PubMed ID: 17367262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for endometrial cancer in women receiving tamoxifen.
    Suh-Burgmann EJ; Goodman A
    Ann Intern Med; 1999 Jul; 131(2):127-35. PubMed ID: 10419429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen in postmenopausal women a safety perspective.
    Robinson E; Kimmick GG; Muss HB
    Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tamoxifen and the uterus.
    Vergote I; Neven P; Vanderick G; van Dam P; Van Belle Y; De Sutter Ph; De Prins F; De Muylder X; Claerhout J; Campo R; Albertyn G
    Eur J Cancer; 1998 Aug; 34 Suppl 4():S1-3. PubMed ID: 9917139
    [No Abstract]   [Full Text] [Related]  

  • 40. Status of antiestrogen breast cancer prevention trials.
    Powles TJ
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.